• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多模态临床影像学纵向评估纳米医学抗炎治疗实验性动脉粥样硬化。

Multimodal clinical imaging to longitudinally assess a nanomedical anti-inflammatory treatment in experimental atherosclerosis.

机构信息

Translational and Molecular Imaging Institute and Imaging Science Laboratories, Mount Sinai School of Medicine, One Gustave L Levy Place, New York, New York 10029, United States.

出版信息

Mol Pharm. 2010 Dec 6;7(6):2020-9. doi: 10.1021/mp100309y. Epub 2010 Nov 8.

DOI:10.1021/mp100309y
PMID:21028895
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3345199/
Abstract

Atherosclerosis is an inflammatory disease causing great morbidity and mortality in the Western world. To increase the anti-inflammatory action and decrease adverse effects of glucocorticoids (PLP), a nanomedicinal liposomal formulation of this drug (L-PLP) was developed and intravenously applied at a dose of 15 mg/kg PLP to a rabbit model of atherosclerosis. Since atherosclerosis is a systemic disease, emerging imaging modalities for assessing atherosclerotic plaque are being developed. (18)F-Fluoro-deoxy-glucose positron emission tomography and dynamic contrast enhanced magnetic resonance imaging, methods commonly used in oncology, were applied to longitudinally assess therapeutic efficacy. Significant anti-inflammatory effects were observed as early as 2 days that lasted up to at least 7 days after administration of a single dose of L-PLP. No significant changes were found for the free PLP treated animals. These findings were corroborated by immunohistochemical analysis of macrophage density in the vessel wall. In conclusion, this study evaluates a powerful two-pronged strategy for efficient treatment of atherosclerosis that includes nanomedical therapy of atherosclerotic plaques and the application of noninvasive and clinically approved imaging techniques to monitor delivery and therapeutic responses. Importantly, we demonstrate unprecedented rapid anti-inflammatory effects in atherosclerotic lesions after the nanomedical therapy.

摘要

动脉粥样硬化是一种炎症性疾病,在西方国家造成了巨大的发病率和死亡率。为了提高糖皮质激素(PLP)的抗炎作用并降低其不良反应,开发了一种该药物的纳米医学脂质体制剂(L-PLP),并以 15mg/kg PLP 的剂量静脉内应用于动脉粥样硬化兔模型。由于动脉粥样硬化是一种全身性疾病,因此正在开发用于评估动脉粥样硬化斑块的新兴成像方式。(18)F-氟代脱氧葡萄糖正电子发射断层扫描和动态对比增强磁共振成像,这两种通常用于肿瘤学的方法,被用于纵向评估治疗效果。在给予单次 L-PLP 剂量后,早在 2 天即可观察到显著的抗炎作用,并且至少持续 7 天。在给予游离 PLP 的动物中未发现明显变化。血管壁中巨噬细胞密度的免疫组织化学分析证实了这些发现。总之,这项研究评估了一种有效的治疗动脉粥样硬化的双管齐下策略,包括对动脉粥样硬化斑块的纳米医学治疗以及应用非侵入性和临床批准的成像技术来监测药物输送和治疗反应。重要的是,我们在纳米医学治疗后在动脉粥样硬化病变中证明了前所未有的快速抗炎作用。

相似文献

1
Multimodal clinical imaging to longitudinally assess a nanomedical anti-inflammatory treatment in experimental atherosclerosis.多模态临床影像学纵向评估纳米医学抗炎治疗实验性动脉粥样硬化。
Mol Pharm. 2010 Dec 6;7(6):2020-9. doi: 10.1021/mp100309y. Epub 2010 Nov 8.
2
Prednisolone-containing liposomes accumulate in human atherosclerotic macrophages upon intravenous administration.静脉注射含泼尼松龙的脂质体后,其会在人类动脉粥样硬化巨噬细胞中蓄积。
Nanomedicine. 2015 Jul;11(5):1039-46. doi: 10.1016/j.nano.2015.02.021. Epub 2015 Mar 17.
3
Anti-tumor activity of liposomal glucocorticoids: The relevance of liposome-mediated drug delivery, intratumoral localization and systemic activity.脂质体糖皮质激素的抗肿瘤活性:脂质体介导的药物递送、肿瘤内定位和全身活性的相关性。
J Control Release. 2011 Apr 10;151(1):10-7. doi: 10.1016/j.jconrel.2010.11.031. Epub 2010 Dec 3.
4
Imaging the efficacy of anti-inflammatory liposomes in a rabbit model of atherosclerosis by non-invasive imaging.通过无创成像评估抗炎脂质体在兔动脉粥样硬化模型中的疗效。
Methods Enzymol. 2012;508:211-28. doi: 10.1016/B978-0-12-391860-4.00011-2.
5
Combined PET/DCE-MRI in a Rabbit Model of Atherosclerosis: Integrated Quantification of Plaque Inflammation, Permeability, and Burden During Treatment With a Leukotriene A4 Hydrolase Inhibitor.动脉粥样硬化兔模型中的 PET/DCE-MRI 联合应用:在白三烯 A4 水解酶抑制剂治疗期间斑块炎症、通透性和负荷的综合定量评估。
JACC Cardiovasc Imaging. 2018 Feb;11(2 Pt 2):291-301. doi: 10.1016/j.jcmg.2017.11.030.
6
Pharmaceutical development and preclinical evaluation of a GMP-grade anti-inflammatory nanotherapy.一种GMP级抗炎纳米疗法的药物研发与临床前评估
Nanomedicine. 2015 Jul;11(5):1133-40. doi: 10.1016/j.nano.2015.02.020. Epub 2015 Mar 17.
7
Nanobody-Facilitated Multiparametric PET/MRI Phenotyping of Atherosclerosis.纳米抗体促进的动脉粥样硬化多参数 PET/MRI 表型分析。
JACC Cardiovasc Imaging. 2019 Oct;12(10):2015-2026. doi: 10.1016/j.jcmg.2018.07.027. Epub 2018 Oct 17.
8
Multimodal Positron Emission Tomography Imaging to Quantify Uptake of Zr-Labeled Liposomes in the Atherosclerotic Vessel Wall.多模态正电子发射断层扫描成像定量分析 Zr 标记的脂质体在动脉粥样硬化血管壁中的摄取。
Bioconjug Chem. 2020 Feb 19;31(2):360-368. doi: 10.1021/acs.bioconjchem.9b00256. Epub 2019 Jun 7.
9
PET Imaging of Liposomal Glucocorticoids using Zr-oxine: Theranostic Applications in Inflammatory Arthritis.Zr-oxine 标记脂质体糖皮质激素的 PET 成像:在炎症性关节炎中的治疗应用。
Theranostics. 2020 Feb 26;10(9):3867-3879. doi: 10.7150/thno.40403. eCollection 2020.
10
Pioglitazone modulates vascular inflammation in atherosclerotic rabbits noninvasive assessment with FDG-PET-CT and dynamic contrast-enhanced MR imaging.吡格列酮调节动脉粥样硬化兔血管炎症:FDG-PET-CT 和动态对比增强磁共振成像的无创评估。
JACC Cardiovasc Imaging. 2011 Oct;4(10):1100-9. doi: 10.1016/j.jcmg.2011.04.020.

引用本文的文献

1
The Heart-Brain Axis in the Artificial Intelligence Era: Integrating Old and New Insights Towards New Targeting and Innovative Neuro- and Cardio-Therapeutics.人工智能时代的脑心轴:整合新旧见解以实现新的靶向及创新神经和心脏治疗
Int J Mol Sci. 2025 Aug 24;26(17):8217. doi: 10.3390/ijms26178217.
2
Effect of Size and Targeting Agent on Biodistribution of Polystyrene Nanoparticles in Apolipoprotein E Knock-Out and Wild-Type Mice.尺寸和靶向剂对载脂蛋白E基因敲除小鼠和野生型小鼠体内聚苯乙烯纳米颗粒生物分布的影响
Diagnostics (Basel). 2025 Aug 25;15(17):2140. doi: 10.3390/diagnostics15172140.
3
Nano-formulations in disease therapy: designs, advances, challenges, and future directions.

本文引用的文献

1
Liposomal glucocorticoids as tumor-targeted anti-angiogenic nanomedicine in B16 melanoma-bearing mice.脂质体糖皮质激素作为荷B16黑色素瘤小鼠的肿瘤靶向抗血管生成纳米药物
J Steroid Biochem Mol Biol. 2008 Jul;111(1-2):101-10. doi: 10.1016/j.jsbmb.2008.05.004. Epub 2008 Jul 7.
2
Form to function: current and future roles for atherosclerosis imaging in drug development.形式决定功能:动脉粥样硬化成像在药物研发中的当前及未来作用
Nat Rev Drug Discov. 2008 Jun;7(6):517-29. doi: 10.1038/nrd2588. Epub 2008 May 16.
3
Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations.
疾病治疗中的纳米制剂:设计、进展、挑战及未来方向。
J Nanobiotechnology. 2025 May 30;23(1):396. doi: 10.1186/s12951-025-03442-7.
4
Emerging Trends and Innovations in the Treatment and Diagnosis of Atherosclerosis and Cardiovascular Disease: A Comprehensive Review towards Healthier Aging.动脉粥样硬化与心血管疾病治疗和诊断的新趋势与创新:迈向健康老龄化的全面综述
Pharmaceutics. 2024 Aug 3;16(8):1037. doi: 10.3390/pharmaceutics16081037.
5
Nanomedicines for cardiovascular disease.心血管疾病的纳米药物
Nat Cardiovasc Res. 2023 Apr;2(4):351-367. doi: 10.1038/s44161-023-00232-y. Epub 2023 Apr 3.
6
Nanoparticles as Drug Delivery Systems for the Targeted Treatment of Atherosclerosis.纳米颗粒作为药物传递系统用于动脉粥样硬化的靶向治疗。
Molecules. 2024 Jun 17;29(12):2873. doi: 10.3390/molecules29122873.
7
Targeted Nanotheransotics: Integration of Preclinical MRI and CT in the Molecular Imaging and Therapy of Advanced Diseases.靶向纳米治疗学:在先进疾病的分子成像和治疗中整合临床前 MRI 和 CT。
Nanotheranostics. 2024 Apr 23;8(3):401-426. doi: 10.7150/ntno.95791. eCollection 2024.
8
Targeting macrophages with multifunctional nanoparticles to detect and prevent atherosclerotic cardiovascular disease.利用多功能纳米颗粒靶向巨噬细胞检测和预防动脉粥样硬化性心血管疾病。
Cardiovasc Res. 2024 Jul 2;120(8):819-838. doi: 10.1093/cvr/cvae099.
9
Regenerative Medicine and Nanotechnology Approaches against Cardiovascular Diseases: Recent Advances and Future Prospective.对抗心血管疾病的再生医学与纳米技术方法:最新进展与未来展望
Curr Stem Cell Res Ther. 2025;20(1):50-71. doi: 10.2174/011574888X263530230921074827.
10
Nanomedicine for Diagnosis and Treatment of Atherosclerosis.纳米医学用于动脉粥样硬化的诊断和治疗。
Adv Sci (Weinh). 2023 Dec;10(36):e2304294. doi: 10.1002/advs.202304294. Epub 2023 Oct 28.
18F-FDG PET用于动脉粥样硬化炎症成像:颈动脉、髂动脉和股动脉摄取的可重复性、量化方法及建议
J Nucl Med. 2008 Jun;49(6):871-8. doi: 10.2967/jnumed.107.050294. Epub 2008 May 15.
4
Detection of neovessels in atherosclerotic plaques of rabbits using dynamic contrast enhanced MRI and 18F-FDG PET.使用动态对比增强磁共振成像(MRI)和18F-氟代脱氧葡萄糖正电子发射断层显像(PET)检测兔动脉粥样硬化斑块中的新生血管。
Arterioscler Thromb Vasc Biol. 2008 Jul;28(7):1311-7. doi: 10.1161/ATVBAHA.108.166173. Epub 2008 May 8.
5
The year in atherothrombosis.动脉粥样硬化血栓形成的这一年。
J Am Coll Cardiol. 2008 Mar 4;51(9):944-55. doi: 10.1016/j.jacc.2007.12.018.
6
Antitumor activity and tumor localization of liposomal glucocorticoids in B16 melanoma-bearing mice.脂质体糖皮质激素在荷B16黑色素瘤小鼠体内的抗肿瘤活性及肿瘤定位
J Control Release. 2008 Apr 21;127(2):131-6. doi: 10.1016/j.jconrel.2008.01.008. Epub 2008 Jan 30.
7
Imaging of atherosclerotic cardiovascular disease.动脉粥样硬化性心血管疾病的影像学检查
Nature. 2008 Feb 21;451(7181):953-7. doi: 10.1038/nature06803.
8
Antitumor activity of liposomal prednisolone phosphate depends on the presence of functional tumor-associated macrophages in tumor tissue.脂质体磷酸泼尼松龙的抗肿瘤活性取决于肿瘤组织中功能性肿瘤相关巨噬细胞的存在。
Neoplasia. 2008 Feb;10(2):108-17. doi: 10.1593/neo.07913.
9
(18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials.(18)氟脱氧葡萄糖正电子发射断层扫描成像检测动脉粥样硬化斑块炎症具有高度可重复性:对动脉粥样硬化治疗试验的意义
J Am Coll Cardiol. 2007 Aug 28;50(9):892-6. doi: 10.1016/j.jacc.2007.05.024. Epub 2007 Aug 13.
10
Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography.使用纳米颗粒造影剂进行计算机断层扫描对巨噬细胞的无创检测。
Nat Med. 2007 May;13(5):636-41. doi: 10.1038/nm1571. Epub 2007 Apr 8.